Alefacept is another fusion protein, between an immunoglobulin and the CD 58 receptor ( = LFA3, leucocyte function associated antigen 3). Alefacept is used in the treatment of Psoriasis.
Atacicept is a fusion protein that targets the B lymphocyte TACI receptor.